Most thyroid cancers are closely related to MAPK, VEGF, and PI3K signaling pathways, while BRAF, RAS and RET genes have higher mutation rates, which provides molecular targets for thyroid cancer (Thomas et al., 2014). This evidence concerns the gene RET and thyroid gland carcinoma.